Sleep Studies Market Report 2026

The sleep studies market size has grown strongly in recent years. It will grow from $6.42 billion in 2025 to $6.97 billion in 2026 at a compound annual growth rate (CAGR) of 8.5%. The growth in the historic period can be attributed to rising awareness of sleep disorders, expansion of sleep clinics and diagnostic centers, increased diagnosis of obstructive sleep apnea, growing geriatric population, availability of advanced sleep monitoring devices.

The sleep studies market size is expected to see strong growth in the next few years. It will grow to $9.55 billion in 2030 at a compound annual growth rate (CAGR) of 8.2%. The growth in the forecast period can be attributed to increasing demand for remote diagnostics, rising integration of ai-based sleep analytics, expansion of home-based healthcare services, growing focus on personalized sleep therapy, increasing investments in digital health diagnostics. Major trends in the forecast period include increasing adoption of home sleep testing devices, rising use of wireless and wearable sleep monitoring systems, growing integration of multi-parameter diagnostic platforms, expansion of remote sleep disorder diagnosis services, enhanced focus on patient-centric sleep assessments.

The rising prevalence of sleep disorders is expected to drive the growth of the sleep studies market in the coming years. Sleep disorders are medical conditions that disrupt normal sleep patterns, causing difficulties in falling asleep, staying asleep, or achieving restorative rest. The increase in sleep disorders is largely driven by higher screen time, which interferes with the body’s natural sleep-wake cycle by suppressing melatonin production. Sleep studies assist in diagnosing these disorders by monitoring brain activity, breathing, and body movements, offering essential insights for accurate treatment and management. For instance, in 2024, according to The Sleep Charity, a UK-based non-profit organization, approximately 2.5 million people in the UK are affected by obstructive sleep apnea hypopnea syndrome (OSAHS), while 37% of adults experience insomnia. Therefore, the rising prevalence of sleep disorders is fueling the growth of the sleep studies market.

Major companies in the sleep studies market are focusing on innovations in sleep-disordered breathing care, such as automatic breathing-stabilizer algorithms, which provide real-time adaptive support and enhance sleep apnea therapy outcomes. Automatic breathing-stabilizer algorithms are intelligent systems that continuously monitor each breath and automatically adjust pressure to maintain stable ventilation during irregular or absent breathing. For instance, in February 2024, ResMed Inc., a U.S.-based medical device and digital health company, launched the AirCurve 11 series, bilevel devices built on the AirSense 11 platform. These devices integrate adaptive airway support (ASV and VAuto), dual-level pressure algorithms, and cloud connectivity with tools like Care Check-In and Personal Therapy Assistant to improve remote monitoring, patient engagement, and therapy adherence. Featuring integrated humidification, automatic data uploads, and over-the-air updates, the AirCurve 11 supports in-lab titration follow-up, home sleep apnea therapy for both obstructive and central events, and remote patient management programs, enhancing comfort, reducing in-person visits, and streamlining care pathways.

In May 2025, ResMed Inc., a US-based medical equipment company, acquired VirtuOx for an undisclosed amount. This acquisition enables ResMed to strengthen its position in the sleep and respiratory care market by expanding its portfolio of home-based diagnostic solutions. VirtuOx Inc. is a US-based company specializing in home-based sleep studies for diagnosing conditions such as obstructive sleep apnea and insomnia.

Major companies operating in the sleep studies market are Koninklijke Philips NV, Itamar Medical Ltd, ResMed Inc, Cadwell Industries Inc, Singular Sleep LLC, SleepMed Inc, BMC Medical Co Ltd, BioSerenity Inc, Snap Diagnostics Inc, DeVilbiss Healthcare LLC, Omni Sleep Health, SOVA Health, Nihon Kohden Corporation, Natus Medical Incorporated, Compumedics Limited, SOMNOmedics GmbH, Neurosoft Ltd, Cleveland Medical Devices Inc, Advanced Brain Monitoring Inc, SOMNOmed Ltd, Vyaire Medical Inc, Masimo Corporation.

North America was the largest region in the sleep studies market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sleep studies market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the sleep studies market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the sleep studies market by increasing costs of imported sensors, monitoring devices, diagnostic electronics, and software-enabled hardware used in polysomnography, EEG, ECG, and home sleep testing systems. Healthcare providers in North America and Europe are most affected due to dependence on imported medical devices, while Asia-Pacific faces higher costs for export-oriented manufacturing. These tariffs are raising capital expenditure for sleep labs and diagnostic centers and slowing equipment upgrades. However, they are also encouraging local device manufacturing, regional supplier partnerships, and development of cost-optimized diagnostic platforms tailored to domestic healthcare systems.

The sleep studies market research report is one of a series of new reports that provides sleep studies market statistics, including sleep studies industry global market size, regional shares, competitors with a sleep studies market share, detailed sleep studies market segments, market trends and opportunities, and any further data you may need to thrive in the sleep studies industry. This sleep studies market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Sleep studies refer to a series of diagnostic tests and evaluations conducted to monitor and analyze a person’s sleep patterns, behaviors, and physiological functions during sleep. These studies help identify sleep disorders such as sleep apnea, insomnia, and restless leg syndrome, enabling healthcare providers to develop effective treatment plans.

The primary types of sleep studies include polysomnography (PSG) machines, electroencephalography (EEG), electrocardiography (EKG or ECG), electromyography (EMG), respiratory inductive plethysmography (RIP) belts, breathing sensors, and video and audio monitoring. Polysomnography (PSG) machines are medical devices used to perform comprehensive sleep studies by recording multiple physiological parameters during sleep. Sleep studies are conducted in various settings, including home sleep testing and in-lab testing. They are indicated for conditions such as obstructive sleep apnea, insomnia, restless leg syndrome, circadian rhythm sleep disorders, narcolepsy, REM sleep disorders, periodic limb movement disorders, bruxism, and others. End users include clinics and ambulatory surgical centers (ASCs), sleep testing centers, home care providers, diagnostic laboratories, and more.

The sleep studies market includes revenues earned by entities by providing services such as polysomnography, home sleep testing, diagnostic consultations, multiple sleep latency testing (MSLT), and maintenance of wakefulness testing (MWT) and related products including CPAP machines, sleep monitoring devices, electrodes, sensors, and data analysis software. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.